Author: Craig Boerner
Effective medications for opioid use disorder rarely used
Aug. 7, 2023—Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.
World-first clinical trial to help millions with penicillin allergies
Jul. 17, 2023—Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.
Musical rhythms shown to improve language processing in children with Developmental Language Disorder
Jul. 12, 2023—Musical rhythms can help children with speech and language processing difficulties in finding their voice by improving their capacity to repeat sentences they just heard, according to a study led by a Western Sydney University researcher and co-authored by Vanderbilt University Medical Center.
Rett syndrome drug studied at Vanderbilt approved for patients
Jul. 7, 2023—The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Study finds Mark Cuban’s Cost Plus Drug Company could save taxpayers millions on Medicare generic oncology drugs
Jun. 8, 2023—Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.
Physical security pilot program ongoing
Jun. 5, 2023—Vanderbilt University Medical Center is piloting several new physical security measures, including metal detectors.
Physical security pilot program begins in May
May. 4, 2023—Vanderbilt University Medical Center (VUMC) is piloting several new physical security measures, including metal detectors, starting in May.
Study shows ketamine could be beneficial for treating brain injury in children
Apr. 4, 2023—Vanderbilt research shows a common anesthesia drug could be beneficial in reducing pressure inside the skull of children with traumatic brain injuries.
More U.S. prostate cancer patients choosing active surveillance
Apr. 3, 2023—A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.
New procedure helps patients avoid leg amputation
Mar. 30, 2023—More than 75% of patients facing amputation from the most severe form of peripheral artery disease were able to keep their limb after an innovative treatment as part of a multicenter study published in the New England Journal of Medicine.
Urology fellowship program celebrated after 20 years
Mar. 30, 2023—The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center.
Study sheds light on drug’s impact on diabetes progression
Mar. 23, 2023—A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.
